Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8094452 | 0.78 | MGLL (0.40) | MGLLSMN1; SMN2 | |
| SCHEMBL4395989 | 0.74 | — | — | |
| SCHEMBL17848462 | 0.70 | GPR119 (0.46) | — | |
| SCHEMBL7290045 | 0.69 | — | — | |
| SCHEMBL1834489 | 0.69 | — | — | |
| SCHEMBL18784063 | 0.69 | — | — | |
| SCHEMBL1481870 | 0.69 | — | — | |
| SCHEMBL11829900 | 0.66 | MGLL (0.40) | MGLLSMN1; SMN2 | |
| SCHEMBL17393258 | 0.63 | — | — | |
| SCHEMBL5191090 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117105961-B | High-temperature sodium ion battery and vehicle thereof | 浙江华宇钠电新能源科技有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-117105961-A | High-temperature sodium ion battery and vehicle thereof | 浙江华宇钠电新能源科技有限公司 | 2023-11-24 | — | — | CN | claimed |
| CN-111211355-A | High-voltage lithium ion battery electrolyte additive, electrolyte and battery thereof | 松山湖材料实验室 | 2020-05-29 | — | — | CN | claimed |
| CN-117105961-B | High-temperature sodium ion battery and vehicle thereof | 浙江华宇钠电新能源科技有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-117105961-A | High-temperature sodium ion battery and vehicle thereof | 浙江华宇钠电新能源科技有限公司 | 2023-11-24 | — | — | CN | disclosed |
| EP-3374368-B1 | 1,1'-SULFANEDIYL-DI-BETA-D-GALACTOPYRANOSIDES AS INHIBITORS OF GALECTINS | GALECTO BIOTECH AB (DK) | 2022-06-01 | — | — | EP | disclosed |
| CN-113394451-A | Lithium ion battery electrolyte containing unsaturated bond silane additive and lithium ion battery | 杉杉新材料（衢州）有限公司 | 2021-09-14 | — | — | CN | disclosed |
| US-10730902-B2 | 1,1 ′-sulfanediyl-di-beta-D-galactopyranosides as inhibitors of galectins | GALECTO BIOTECH AB (DK) | 2020-08-04 | — | — | US | disclosed |
| CN-111211355-A | High-voltage lithium ion battery electrolyte additive, electrolyte and battery thereof | 松山湖材料实验室 | 2020-05-29 | — | — | CN | disclosed |
| US-20180327440-A1 | NOVEL GALACTOSIDE INHIBITORS OF GALECTINS | GALECTO BIOTECH AB (DK) | 2018-11-15 | — | — | US | disclosed |
| CN-108602848-A | Inhibitor of-two-β-D- galactopyranosides of 1,1 '-sulfane diyl as galactose agglutinin | 格莱克特生物技术公司 | 2018-09-28 | — | — | CN | disclosed |
| WO-2017080973-A1 | 1,1 '-SULFANEDIYL-DI-BETA-D-GALACTOPYRANOSIDES AS INHIBITORS OF GALECTINS | GALECTO BIOTECH AB (DK) | 2017-05-18 | — | — | WO | disclosed |
| US-20150232429-A1 | SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS | THE SCRIPPS RESEARCH INSTITUTE | 2015-08-20 | — | — | US | disclosed |
| US-9018205-B2 | Substituted pyrimidinyl-amines as protein kinase inhibitors | THE SCRIPPS RESEARCH INSTITUTE (US) | 2015-04-28 | — | — | US | disclosed |
| EP-2200436-B1 | SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS | SCRIPPS RESEARCH INST (US) | 2015-01-21 | — | — | EP | disclosed |
| US-8530480-B2 | Substituted pyrimidinyl-amines as protein kinase inhibitors | THE SCRIPPS RESEARCH INSTITUTE (US) | 2013-09-10 | — | — | US | disclosed |
| US-20130231336-A1 | SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2013-09-05 | — | — | US | disclosed |
| US-20100298312-A1 | SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2010-11-25 | — | — | US | disclosed |
| EP-2200436-A1 | SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS | The Scripps Research Institute (US) | 2010-06-30 | — | — | EP | disclosed |
| WO-2009032861-A1 | SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2009-03-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180327440-A1 | NOVEL GALACTOSIDE INHIBITORS OF GALECTINS | LGALS1, LGALS3, LGALS3BP | MGLL 1262/4885GAA 92/4885SMN1; SMN2 3549/4885 |
| US-10730902-B2 | 1,1 ′-sulfanediyl-di-beta-D-galactopyranosides as inhibitors of galectins | LGALS1, LGALS3, LGALS2 | MGLL 1176/4885GAA 120/4885SMN1; SMN2 2393/4885 |
| US-20130231336-A1 | SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS | MAP3K20, MAP3K5, MAP3K7 | MGLL 4531/4885GAA 3640/4885SMN1; SMN2 3989/4885 |
| US-20100298312-A1 | SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS | MAP3K20, MAP3K5, MAP3K7 | MGLL 4531/4885GAA 3640/4885SMN1; SMN2 3989/4885 |
| US-20150232429-A1 | SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS | MAP3K20, MAP3K5, MAP3K7 | MGLL 4531/4885GAA 3640/4885SMN1; SMN2 3989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.